CQENS Technologies moved the exercise periods for its 7,000,000-share Series A and Series B warrants to September 30, 2029 through September 30, 2032. Investors now have a revised exercise timetable to assess alongside the unchanged $5.31 per-share price and the aggregate 21,000,000-warrant package.

Key Highlights

  • CQENS Technologies’ warrants carry an exercise price of $5.31 per share.
  • The company’s Warrant package covers an aggregate of 21,000,000 common stock warrants.
  • CQENS Technologies may accelerate commencement or extend expiration dates by notifying Xten Capital Group.

Xten Capital Group agreed to delay the Series B timetable in exchange for extending Series A on the same schedule. The amendment changes when those warrants can be exercised while preserving the $5.31 per-share exercise price and other terms that were not specifically modified. The warrants originated in connection with CQENS Technologies’ 2020 purchase of intellectual property Assets from Xten, which the company identified as a related party. The consideration included warrants covering an aggregate of 21,000,000 shares of common stock, with Series A, Series B and Series C instruments each exercisable for 7,000,000 shares. The Series C warrant’s stated exercise period runs from September 30, 2029 through September 30, 2032.

Series A and Series B Terms Rewritten

CQENS Technologies’ board approved the amendment effective September 3, 2026. The revised Series A period begins September 30, 2029 and ends September 30, 2032, while the revised Series B period follows the same dates. CQENS Technologies may accelerate the start of either exercise period or extend its expiration date by notifying Xten. The amendment controls if its terms conflict with the warrants, and provisions not specifically changed remain preserved. William P. Bartkowski signed for CQENS Technologies as secretary and chief administrative officer, while Alexander Chong signed for Xten as chairman and chief executive officer.